S1神经根脊髓脑膜黑色素细胞瘤8年随访:病例报告与文献复习
本文报告一例32岁女性左侧S1神经根周围、延伸至左侧椎旁间隙的肿瘤,表现为持续左腿痛6个月,T1高信号、T2低信号且均匀强化,行保留S1神经根的整块切除。术后症状明显缓解,随访未见局部复发,作者结合文献认为该病罕见、良性但易误诊为神经鞘瘤或脑膜瘤,HMB-45有助诊断,完整手术切除为主要治疗。
要点
- S1神经根内脊髓脑膜黑色素细胞瘤罕见且为良性,影像学易误诊为神经鞘瘤或脑膜瘤。
- HMB-45、S-100蛋白和波形蛋白免疫组化阳性有助诊断,HMB-45被视为重要诊断标志物。
- 完整手术切除是首选治疗,本例保留S1神经根整块切除后症状明显缓解且未见局部复发。
核心结论
- 神经根内脊髓脑膜黑色素细胞瘤罕见且为良性,诊断困难,常被误诊为神经鞘瘤或脑膜瘤。
- HMB-45被认为是脑膜黑色素细胞瘤诊断的重要标志物。
- 完整手术切除推荐作为主要治疗,放疗、化疗等辅助治疗效果存在争议。
- 该病的复发率和转移率仍不明确。
研究设计与样本
- 个案报告并复习既往文献,患者为32岁女性,左侧S1神经根周围肿瘤延伸至左侧椎旁间隙,持续左腿痛6个月。
- 比较本例治疗结果与既往文献报道。
- 对肿瘤行整块切除并保留S1神经根,行组织学与免疫组化检查。
主要发现
- 肿瘤T1加权像高信号、T2加权像低信号,呈均匀强化。
- 大体为柔软、有包膜、边界清楚、黑色素性病变。
- 免疫组化显示肿瘤细胞HMB-45、S-100蛋白和波形蛋白阳性。
- 术后患者症状明显缓解,未见局部复发迹象。
关键数值与推荐
- 免疫组化:HMB-45、S-100蛋白、波形蛋白阳性。
- 影像学:T1高信号、T2低信号、均匀强化。
- 治疗:整块切除并保留S1神经根。
临床怎么用
- 对疑似神经鞘瘤或脑膜瘤的椎管内肿瘤,应将脑膜黑色素细胞瘤纳入鉴别诊断。
- 术中争取完整切除并尽量保留神经根,术后可用HMB-45等免疫组化协助确诊。
- 辅助放疗、化疗的效果尚有争议,需个体化评估并长期随访复发与转移。
局限性
- 为单例个案报告,证据级别有限。
- 放疗、化疗等辅助治疗效果存在争议,复发率和转移率仍不明确。
- 随访8年未见复发仅为该例结果,不能外推至总体人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary melanocytic neoplasms in the central nervous system are rare lesions arising from leptomeningeal melanocytes. These lesions produce neural deficits that resemble those of a meningioma or a schwannoma radiologically. CASE DESCRIPTION: A tumor around the left S1 root with an extension into the left paraspinal compartment was identified in a 32-year-old female with persistent left leg pain for 6 months. The tumor was hyperintense on T1-weighted image and hypointense on T2-weighted image with a homogeneous enhancement. The clinical features, radiologic presentations, treatment choice, and pathologic characteristic were illustrated. The treatment outcome was compared with those reported in the previous literature. The tumor was en-bloc resected with the S1 nerve root reserved. Grossly, the tumor was a soft, capsulated, well-circumscribed, black pigmented lesion. Immunohistochemistry revealed that the tumor cells were positive for HMB-45, S-100 protein, and vimentin. The patient's symptoms were greatly relieved postoperatively. No signs of local recurrence were observed. CONCLUSIONS: Spinal meningeal melanocytoma inside the nerve root is rare and benign. It is difficult to diagnose and often misdiagnosed as schwannoma or meningioma. HMB-45 has been suggested as a significant marker for the diagnosis of meningeal melanocytoma. Complete surgical resection is recommended as the primary treatment. Radiotherapy, chemotherapy, and other treatments can be selected as adjuvant therapies, but their effects are controversial. The recurrence and metastasis rates also remain unclear.
引用
- Yin M, Ma J, Ye J, et al. 8-Year Follow-up for Woman with Spinal Meningeal Melanocytoma in S1 Nerve Root: Case Report and Literature Review. World Neurosurg. 2019. PMID: 31426249. doi:10.1016/j.wneu.2019.05.147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。